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ABSTRACT 
Background 
Recent research suggests that mental health problems in spouses of cancer survivors are associated with worse 
mental health in the survivors themselves. Adequately treating spousal mental health problems therefore 
represents an opportunity to improve outcomes for both cancer survivors and their co-surviving family 
members. 
Objective 
Using nationally representative data, this study sought to determine how depression treatment differs between 
spouses of cancer survivors with depression compared to the general married population and assess rural/urban 
disparities in treatment. 
Design 
The design of the study is cross sectional. 
Participants 
Data are from the Medical Expenditures Panel Survey, a household-based survey of US adults; we concatenated 
data from 2004 to 2013. We identified spouses of cancer survivors (n = 225) and a comparison group of married 
adults (n = 3678). 
Main Measures 
Key measures included depression, guideline concordance of depression treatment (at least four prescriptions 
related to depression treatment, or at least eight psychotherapy or counseling visits), and sociodemographic 
characteristics. Logistic regressions evaluated the association between whether their spouse had cancer and 
receipt of guideline-concordant treatment, controlling for sociodemographic characteristics; secondary analyses 
included rurality as a moderator. Analyses were weighted to account for the complex sampling design. 
Key Results 
Spouses of cancer survivors were 33% less likely to receive guideline-concordant depression treatment than 
comparison spouses (odds ratio (OR) 0.67, 95% confidence interval (CI) 0.45–0.99), controlling for covariates. 
Rural-urban disparities were observed: rural spouses of cancer survivors were 72% less likely to receive 
guideline-concordant treatment (OR 0.28, 95% CI 0.11–0.68) than rural comparison spouses. Spouses of cancer 
survivors and comparison spouses were no different in their receipt of any treatment versus no treatment. 
Conclusions 
Spouses of cancer survivors with depression may be at increased risk of non-guideline-concordant depression 
treatment, particularly in rural areas. The findings have implications for identifying and educating individuals 
with depression in primary care and other clinical areas. 
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INTRODUCTION 
There are an estimated 15.5 million cancer survivors in the USA1 (defined as any person diagnosed with cancer, 
from the time of initial diagnosis2). Given that the adverse impacts of cancer extend beyond the cancer patient 
themselves,2, 3 millions more family members are considered “co-survivors” of the disease. Co-survivors often 
serve as informal cancer caregivers, playing a critical role in the well-being of individuals with cancer. In addition 
to supporting the survivor through their illness, co-survivors often struggle with their own emotional distress. 
The caregivers of cancer survivors have been found to have equal, if not greater, rates of depression than the 
survivors themselves (12–59%).4 Spouses in particular often experience greater burden, strain, or distress than 
other family caregivers5, 6 and are more likely than the general population to experience depression.7, 8 
Recent research has shown that when their spouses experienced depressed mood, cancer survivors were four 
times more likely to become depressed over the next year,9, 10 supporting theoretical and emerging empirical 
work around the interrelationship between families/caregivers and cancer survivors.11 Given the association 
between depression in cancer survivors and adverse outcomes ranging from decreased medication adherence 
to premature mortality,12–17 appropriately treating spousal depression may afford an opportunity to improve 
outcomes for both cancer survivors and their spouses. However, despite the existence of effective 
pharmacotherapy and psychotherapy treatments,18many cancer caregivers (including spouses) may be at risk 
for under-treatment of depression,19 as informal caregivers often report struggling with self-care,20 and likely 
face time, cost, and access constraints that may be barriers to receiving health care. Furthermore, low 
socioeconomic status has been associated with less adequate depression treatment21 and rural populations 
face known mental health treatment challenges.22 Yet, we know very little about the unique needs and 
outcomes of rural caregivers. 
This study sought to evaluate how cancer caregivers with depression currently receive treatment in the USA. 
Specifically, we sought to determine how treatment patterns for spouses of cancer survivors differ from the 
general population, and whether there are socioeconomic or geographic disparities in treatment rates. Better 
understanding treatment patterns and disparities among cancer caregivers will inform medical practice and 
caregiver education, with important implications for the well-being of cancer survivors and their families. 
METHODS 
Data were obtained from the Medical Expenditures Panel Survey (MEPS). The MEPS is a household-based, 
nationally representative survey of US adults. Each year, the MEPS collects data on a new panel of households 
and each panel is followed for five time points over a 2.5-year period. For this study, we concatenated data from 
panels 9–17 collected between 2004 and 2013. Detailed information about MEPS methodology and data is 
available at http://meps.ahrq.gov. 
Sample Selection 
MEPS respondents were eligible for this study if they (1) were married to someone with or without cancer and 
(2) reported having depression. To identify depressed spouses of cancer survivors, we first used the MEPS 
medical conditions file to identify adults who had a cancer-related health-problem, medical event, or disability. 
Adults with any type of cancer or malignancy (excluding those with only non-melanoma skin cancer) were 
categorized as survivors. All other adults were categorized as general population. 
We then linked both survivors and the general population with their spouses (if applicable) using a spousal ID. 
Depression status was then determined using the Conditions Enumerations section of the MEPS, in which 
participants reported their physical and mental/emotional conditions, as well as conditions related to any 
medical events or disabilities. Using this information, MEPS coders assign truncated ICD-9 codes. Participants 
with ICD-9 code 296 or 311, during any round, were classified as having depression. All depressed spouses of 
cancer survivors were included in the final sample; couples in which both spouses had cancer were excluded. In 
the comparison sample of depressed spouses in the general population, when couples both reported depression 
an index spouse was randomly selected. This resulted in an eligible sample of 4001 adults (n = 229 spouses of 
cancer survivors, n = 3772 comparison spouses; Fig. 1). 
 
Figure 1. Identification of eligible participants. MEPS Medical Expenditures Panel Survey. Data are from 2004 
to 2013. 
Key Measures 
Dependent Variable: Depression Treatment 
Based on guidelines from the 2010 American Psychological Association23and the definitions used in previous 
research,21, 24–26 guideline-concordant treatment of depression was defined as receiving at least four 
prescriptions related to depression treatment or at least eight outpatient or office-based psychotherapy or 
counseling visits. Using the MEPS prescription file, we identified whether a respondent received prescriptions 
indicated for the treatment of depression as defined by Multum Lexicon Drug Database (subclassification code 
249).27 MEPS respondents reported the name of any prescribed medicine they purchased or otherwise 
obtained during each round. Each original purchase and any subsequent refills were recoded as distinct 
medications. Using the MEPS Outpatient Department Visits and MEPS Office-Based Medical Provider Visits files, 
we identified the number of visits involving psychotherapy. Prescriptions and psychotherapy visits were counted 
over a rolling three-round period (i.e., time points 1–3, time points 2–4, and/or time points 3–5); four 
prescriptions or eight psychotherapy visits in any period were counted as receiving guideline-concordant 
treatment. Prescriptions were assumed to be for a minimum of 30 days, and psychotherapy for a minimum of 
30 min. We also categorized respondents who had received any treatment versus no treatment for depression. 
Independent Variable: Co-Survivor/Comparison Status 
Co-survivors (here referring specifically to spouses of cancer survivors) and comparisons (spouses in the general 
population) with depression were identified as described above. 
Covariates 
Following Keller et al.,26 predisposing, enabling, and need factors were considered as covariates.28 Predisposing 
factors included age, gender, race/ethnicity (white non-Hispanic versus other), education (high school or less 
versus some college or more), employment status (employed versus not employed), percent of the federal 
poverty level (100, 200, 300, or 400%+), rurality (Metropolitan Statistical Area, rural versus urban), and region of 
residence (Northeast, Midwest, South, or West). Enabling factors included health insurance coverage (any 
public, private only, or uninsured) and having a usual source of care (yes versus no). Need factors included 
number of health conditions, self-reported health (good/fair/poor versus excellent/very good), health service 
use in the past 12 months (low < 4 visits versus high 4+ visits), and level of depressed mood (Patient Health 
Questionnaire-2 29). Covariates were measured at baseline (round 1); if baseline data were missing, the variable 
was back-filled with data from the next available time point. For co-survivors, we also assessed the survivor’s 
cancer type (blood, breast, colorectal, prostate, other, or multiple) and time since diagnosis (<5 years, 5+ years, 
or unknown/unreported) as reported in the medical conditions file; these data were for descriptive purposes 
only. 
Analytic Approach 
Descriptive statistics (cross-tabulations; means and standard deviations) were calculated on all covariates. Co-
survivors and comparison spouses were compared on all covariates using chi-squared and t tests. Among co-
survivors and comparison spouses with depression, we calculated the proportion receiving guideline-concordant 
treatment, and any treatment. We then ran a bivariate logistic regression, regressing receipt of guideline-
concordant treatment on co-survivor/comparison status. The predisposing, enabling, and need covariates and 
panel number were then added to this model in a multivariable logistic regression. Finally, moderation was 
assessed by including interaction terms for (1) rurality*co-survivor status and (2) poverty*co-survivor status in 
separate regressions. All analyses were conducted in SAS (v. 9.4) using survey weighting procedures to adjust for 
the complex sampling frame of the MEPS. 
Approach to Missing Data 
This study was conducted as a complete case analysis, and those with missing covariate data were dropped from 
the analysis (n = 4 spouses of cancer survivors (1.8%) and n = 94 comparison spouses (2.5%)). Those dropped due 
to missing data were slightly older (53 versus 49, p < 0.01), more likely to be from the western USA (38 versus 
25%, p = 0.04), less likely to have a usual source of care (78 versus 87%, p < 0.01), and had fewer health 
conditions (7 versus 9, p < 0.01). They were also less likely to receive guideline-concordant depression treatment 
(50 versus 62%, p = 0.01). They did not differ significantly on other covariates. 
Sensitivity Analysis 
To assess whether our findings are robust to our operationalization of guideline concordance, we conducted 
sensitivity analyses testing six psychotherapy visits (the number often approved by insurance companies) rather 
than eight. 
RESULTS 
Table 1 depicts the characteristics of the samples. Co-survivors were older than comparison spouses (mean ages 
61 versus 50 years, p < 0.0001). Almost two thirds (66%) of the comparisons were female, while 58% of the co-
survivors were female (p = 0.07). Comparisons were also more likely to be employed (56 versus 39%, p < 0.01). 
Most participants in both groups were white non-Hispanic and reported at least some college education. 
Approximately 30% of participants reported incomes at or below 200% of the federal poverty level, and 
approximately 80% lived in an urban area. Co-survivors were more likely to have only private insurance (21 
versus 14%), while comparisons were more likely to be uninsured (8 versus 3%, p < 0.0001). Nearly all 
participants (~90%) reported having a usual source of care. Co-survivors reported more health conditions than 
comparisons (mean conditions: 12 versus 9, p < 0.0001). Co-survivors were also more likely to report poor self-
rated health (69 versus 59%, p = 0.0059) and high service use in the past 12 months (62 versus 50%, p = 0.0037). 
Table 1 Survey Weighted Characteristics of Adults With Depression, Medical Expenditures Panel Survey (2004–
2013) 
  Co-survivors Comparisons P value 
Weighted number 582,548 9,165,501 
 
Unweighted number 225 3,678 
 
  Mean (SD) or % Mean (SD) or 
% 
 
Sociodemographics    
Age (years; mean, SD) 60.93 (0.98) 49.44 (0.27) < 0.0001 
Gender     0.0671 
 Male 42.34 34.12   
 Female 57.66 65.88   
Race/ethnicity     0.5420 
 Other 34.71 36.95   
 White (non-Hispanic) 65.29 63.05   
Education     0.3001 
 High school or less 48.25 44.08   
 Some college or more 51.75 55.92   
Employment status     < 0.0001 
 Not employed 60.68 44.38   
 Employed 39.32 55.62   
Percent of federal poverty level     0.7076 
 100 5.67 6.43   
 200 26.71 23.07   
 300 25.51 28.19   
 400+ 42.11 42.32   
MSA     0.8267 
 Rural 18.22 18.93   
 Urban 81.78 81.07   
Region     0.4201 
 Northeast 22.80 15.28   
 Midwest 23.30 25.26   
 South 33.49 37.18   
 West 20.41 22.29   
Insurance coverage     < 0.0001 
 Any public 75.33 77.17   
 Private only 21.21 14.48   
 Uninsured 3.45 8.35   
Usual source of care     0.1898 
 No 7.88 11.10   
 Yes 92.12 88.90   
Health conditions (mean, SD) 11.62 (0.59) 9.26 (0.13) < 0.0001 
Self-reported health     0.0059 
 Good/fair/poor 68.99 59.08   
 Excellent/very good 31.01 40.92   
Service use (past 12 months)    0.0037 
 Low (< 4 visits) 37.67 49.92   
 High (4+ visits) 62.33 50.08   
Cancer characteristics    
 Cancer type   NA NA 
 Blood 8.43     
 Breast 20.20     
 Colorectal 5.01     
 Prostate 17.69     
 Multiple 7.15     
 Other 41.51     
Time since diagnosis   NA NA 
 < 5 years 45.71     
 5+ years 29.47     
 Unknown/unreported 24.82     
Treatment status   NA NA 
 Not receiving treatment during 
survey period 
64.53     
 Received treatment during survey 
period 
35.47     
SD standard deviation 
In the unadjusted data, two thirds of both co-survivors with depression and comparisons reported receiving 
guideline-concordant treatment (data not tabled). Table 2 shows the results of the weighted multivariable 
logistic regression of the association between co-survivor status (i.e., spouses of cancer survivors with 
depression versus comparison spouses with depression) and receipt of guideline-concordant depression 
treatment. After controlling for covariates, co-survivors were 33% less likely to receive guideline-concordant 
depression treatment (odds ratio [OR] = 0.67, 95% confidence interval [CI] = 0.45–0.99). Predisposing, enabling, 
and need factors were also associated with receipt of guideline-concordant treatment (Table 2; written 
summary available in Online Appendix). 
Table 2 Association Between Spousal Caregiving Status and Guideline Concordant Depression Treatment 
(Medical Expenditures Panel Survey, 2004–2013) 
  Bivariate   Multivariable    
OR 95% CI  OR 95% CI    
Lower Upper 
 
Lower Upper 
Co-survivor/comparison status       
 Spouse of cancer survivor 1.02 0.70 1.49 0.67 0.45 0.99 
Comparison spouse (ref)       
Covariates             
Age (years)       1.01 1.01 1.02 
Gender       
 Male (ref)             
 Female       1.24 1.04 1.47 
Race/ethnicity       
 Other       0.47 0.37 0.60 
 White (non-Hispanic) (ref)             
Education       
 High school or less       0.79 0.66 0.94 
 Some college or more (ref)             
Employment status       
 Not employed for pay       0.78 0.64 0.96 
 Employed (ref)             
Percent of federal poverty level       
 100       0.82 0.58 1.16 
 200       0.72 0.56 0.93 
 300       0.82 0.66 1.02 
 400+ (ref)             
MSA       
 Rural       1.17 0.88 1.55 
 Urban (ref)             
Region       
 Midwest       1.32 1.03 1.69 
 Northeast       1.10 0.83 1.47 
 South       1.14 0.90 1.44 
 West (ref)             
Insurance coverage       
 Any public       1.50 1.14 1.97 
 Private only       1.48 1.06 2.05 
 Uninsured (ref)             
Usual source of care       
 No       0.56 0.43 0.72 
 Yes (ref)             
Health conditions (number)       1.08 1.05 1.10 
Self-reported health       
 Good/fair/poor (ref)             
 Excellent/very good       0.82 0.67 0.99 
Service use (past 12 months)       
 Low (< 4 visits) (ref)             
 High (4+ visits)       1.33 1.12 1.58 
Depressed mooda       1.03 0.98 1.09 
Note: Survey-weighted models; multivariable model also controls for panel number 
OR odds ratio, CI confidence interval 
aMeasured by the Patient Health Questionnaire 2 (one-point increase) 
 
There was a significant interaction between rurality and co-survivor status (pinteraction = 0.02). Rural co-survivors 
were 72% less likely to receive guideline-concordant depression treatment (OR 0.28, 95% CI 0.11–0.68) than 
rural comparisons. Figure 2 shows the predicted probabilities of receipt of guideline-concordant treatment, 
controlling for covariates (with age centered at 50): 40% of rural co-survivors with depression received 
guideline-concordant treatment, versus 71% of rural comparison spouses, 66% of urban comparison spouses, 
and 61% of urban co-survivors. 
 
Figure 2 Predicted probabilities of guideline-concordant treatment among spouses of cancer survivors (“co-
survivors,” blue bars) and comparison spouses in the general population (orange bars), by urbanicity. a 
Significant difference from rural and urban comparisons (p < 0.05); borderline difference from urban co-
survivors (p < 0.10). b Significant difference from rural co-survivors (p < 0.05); borderline difference from 
urban co-survivors (p < 0.10) 
Poverty level did not moderate the association between co-survivor/comparison status and guideline-
concordant treatment (pinteraction = 0.36; data not tabled). There was no association between co-survivor status 
and receipt of any depression treatment versus no treatment (Table 3). In sensitivity analyses, changing the 
definition of guideline concordance from eight psychotherapy visits to six visits did not change the results. 
Table 3 Association Between Spousal Caregiving Status and Receipt of Any Depression Treatment (Medical 
Expenditures Panel Survey, 2004–2013) 
  Bivariate   Multivariable    
OR 95% CI  OR 95% CI    
Lower Upper 
 
Lower Upper 
Co-survivor/comparison status       
 Spouse of cancer survivor 1.16 0.76 1.77 0.81 0.53 1.25 
Comparison spouse (ref)       
Covariates             
Age (years)       1.01 1.00 1.02 
Gender       
 Male (ref)             
 Female       1.43 1.16 1.75 
Race/ethnicity       
 Other       0.43 0.33 0.55 
 White (non-Hispanic) (ref)             
Education       
 High school or less       0.82 0.66 1.03 
 Some college or more (ref)             
Employment status       
 Not employed for pay       0.75 0.60 0.94 
 Employed (ref)             
Percent of federal poverty level       
 100       0.86 0.59 1.27 
 200       0.70 0.53 0.92 
 300       0.90 0.71 1.14 
 400+ (ref)             
MSA       
 Rural       1.21 0.92 1.60 
 Urban (ref)             
Region       
 Midwest       1.10 0.84 1.44 
 Northeast       1.04 0.76 1.44 
 South       1.21 0.95 1.53 
 West (ref)             
Insurance coverage       
 Any public       1.49 1.11 1.99 
 Private only       1.39 0.98 1.99 
 Uninsured (ref)             
Usual source of care       
 No       0.56 0.43 0.73 
 Yes (ref)             
Health conditions (number)       1.10 1.07 1.13 
Self-reported health       
 Good/fair/poor (ref)             
 Excellent/very good       0.84 0.67 1.05 
Service use (past 12 months)       
 Low (< 4 visits) (ref)             
 High (4+ visits)       1.45 1.18 1.78 
Depressed mooda       1.01 0.95 1.08 
Note: Survey-weighted models; multivariable model also controls for panel number 
OR odds ratio, CI confidence interval 
aMeasured by the Patient Health Questionnaire 2 (one-point increase) 
DISCUSSION 
Co-survivors serve as an integral part of the care team for cancer patients, but may also suffer from unaddressed 
emotional needs. We performed an analysis of an existing database and found that spouses of cancer survivors 
were less likely to receive guideline-concordant depression treatment than comparison spouses. Our findings 
support previous research indicating that distressed family caregivers of lung cancer patients underuse mental 
health services.30 In our analysis, co-survivors in rural areas were particularly at risk. We did not observe similar 
disparities in socioeconomic status, and co-survivors and comparisons with depression did not differ in their 
receipt of any depression treatment (versus no depression treatment). To our knowledge, this is the first study 
to evaluate rates of guideline-concordant depression care among caregivers. 
It is noteworthy that we found differences in guideline-concordant treatment, even though all eligible subjects 
reported having depression. One interpretation of this finding is that co-survivors, and particularly rural co-
survivors, are at risk for under-treatment of depression. Under-treatment of depression is prevalent among the 
general population.31Caregivers may be disproportionately affected as they often struggle with self-
care20 which may extend into mental health care.30 Cancer caregivers have reported seeing mental health 
service use as a “last resort” and prioritizing the care recipient’s needs above their own,32 potentially leading 
them to be less likely to seek out or adhere to treatment for their depression. 
In addition, expectations and assumptions around cancer and depression may play a role. Anecdotal evidence 
from our clinical practice suggests that many co-survivors and patients interpret their depression as part of the 
“cancer experience”: they feel that they are supposed to be depressed and assume that it is part of the 
“necessary suffering” of cancer, and therefore do not seek treatment. They may feel that since they cannot 
change the circumstances or their survivor’s diagnosis, they also cannot change or control their depression. 
However, to our knowledge, this mindset has not been examined in the literature. Qualitative and quantitative 
studies are needed to determine to what extent this mindset may act as a modifiable barrier to depression care. 
An alternative explanation of these findings relates to differing levels of depression symptoms and/or treatment 
needs in co-survivors compared to the general population. Although treatment guidelines are a useful tool, they 
are not meant to supersede clinical judgment. It is therefore possible that lower (guideline non-concordant) 
levels of treatment were the best course of care for some co-survivors in this study. Although we controlled for 
level of depressive symptoms to try to mitigate this confounding factor, studies with richer clinical data will be 
needed to thoroughly evaluate this possibility. 
Rural co-survivors received guideline-concordant treatment at particularly low levels. Previous work in the 
general population33 found no overall rural-urban differences in receipt of depression treatment; similarly, in 
our study, rural comparisons were statistically no different than urban comparisons to receive treatment. This 
suggests that caregiving may contribute to under-treatment of depression in rural areas in unique ways. 
Caregiving may amplify barriers to care observed in rural areas, including the well-documented shortage of 
mental health providers34, 35 and possible greater perceptions of stigma and lower belief in the efficacy of and 
need for treatment in samples from rural versus urban areas.36Caregiving in particular is associated with time 
and cost burdens; in rural areas, where the geographical distance to a pharmacy or mental health provider may 
be farther, such time costs may be more likely to present insurmountable barriers to care. 
The findings from this study suggest opportunities for improving treatment of depression in cancer co-survivors, 
ranging from co-survivor education to implications for clinical care. Caregiver-specific interventions, while 
effective at decreasing burden, have not been successful in reducing caregivers’ depression.37 This emphasizes 
the need for guideline-concordant depression treatment for caregivers who are experiencing depression. Given 
the key role primary care plays in delivering mental health care,38, 39 this information may be particularly useful 
for primary care practice. For example, asking about caregiving responsibilities may enable primary care 
providers to identify high-risk patients who will benefit from close follow-up to maximize the probability that 
they persist with their depression treatment. Enhancing mental health referrals with active follow-up may also 
encourage uptake of recommended treatments, and may be particularly important in a rural population. 
Oncology and specialty teams may also have a role in supporting co-survivors’ mental health, by integrating co-
survivors into family-centered cancer care. Several models for such integration are beginning to emerge, 
including multidisciplinary hospital-based caregiver clinics,40 caregiver supports through palliative and hospice 
care,41 and the Family Caregiver Program at the Department of Veterans Affairs.42 Most organizations, 
however, do not yet have a formal, standardized mechanism for integrating co-survivors into cancer 
care.43 Early involvement of palliative care—with an additional emphasis on evaluating caregiver depression 
and stress—may also facilitate optimal mental health care for co-survivors. 
Finally, enhanced patient education may improve depression treatment outcomes for co-survivors. Addressing 
misconceptions about the efficacy and purpose of depression treatment—in general and for caregivers 
specifically—may reduce feelings of futility and improve depression treatment plan adherence. Such education 
may be particularly critical for rural co-survivors, for whom stigma and negative beliefs about depression and 
treatment may be particularly relevant.36 Furthermore, community-level approaches to decreasing cultural 
barriers such as stigma, or increasing access to mental health care may benefit all communities, and rural 
communities in particular. 
This study should be interpreted in light of several limitations. Our definition of guideline-concordant depression 
treatment was guided by several assumptions and estimates made necessary by the dataset. Most panels of the 
MEPS do not include questions about caregiving; actual caregiving involvement (i.e., spouses’ provision of 
emotional, function, or financial support) is therefore assumed rather than documented. We could not assess 
subjects’ adherence to treatment or determine the appropriateness of guideline non-concordant treatment on 
an individual level. This study combined data across cancer types and we were unable to isolate cancer stage; 
carcinomas in situ were therefore included along with later stage cancers. There are some differences between 
the characteristics of the co-survivor and comparison groups. We opted to control for these possible 
confounders in the statistical analysis rather than through matching procedures. Finally, we were only able to 
examine spouses in this dataset; the findings may therefore not be generalizable to other caregiving populations 
or relationships. Nevertheless, this study makes use of a large, national dataset with household-level data, and 
provides compelling, generalizable evidence of differences in treatment for co-surviving spouses with 
depression, particularly in rural areas. The findings should therefore spur future research to determine these 
differences and the long-term impacts of such disparities with more precision. 
In conclusion, this study found that spouses of cancer survivors were less likely to receive guideline-concordant 
treatment for depression than the general population of married adults. Those in rural areas were at particularly 
high risk of potential under-treatment. The findings highlight the need for enhanced follow-up among cancer co-
survivors, to encourage uptake of and adherence to depression treatment. Innovative approaches to addressing 
barriers to mental health care, including family-centered cancer care and community-level approaches to 
depression education and stigma reduction, may also improve co-survivor outcomes, particularly in rural areas. 
Future research should examine and seek to mitigate clinical-, community-, and individual-level barriers to 
depression care for cancer co-survivors, with a focus on how the barriers and solutions may differ by rurality. 
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Appendix 1: Summary of the associations between study covariates 
(predisposing, need, and enabling factors) and receipt of guideline 
concordant treatment among spouses of cancer survivors.  
Among the predisposing, need, and enabling factors, there were several correlates of guideline 
concordant treatment (Table 2), controlling for co-survivor status. Among predisposing factors, older age (OR: 
1.01, 95% CI: 1.01-1.02), female gender (OR:1.24, 95% CI: 1.04-1.47), and living in the Midwest (OR:1.32, 95% CI: 
1.03-1.69) were associated with an increased likelihood of receiving guideline-concordant care, while non-white 
race (OR: 0.47, 95% CI: 0.37-0.60), lower levels of education (OR: 0.79, 95% CI: 0.66-0.94), not working for pay 
(OR: 0.78, 95% CI: 0.64-0.96), lower income (OR:0.72, 95% CI: 0.56-0.93, 200% FPL versus 400%) were associated 
with a decreased likelihood of receiving guideline concordant depression treatment. Among enabling factors 
insurance coverage was associated with an increased likelihood of receiving guideline concordant treatment 
(any public insurance, OR: 1.50, 95% CI: 1.14- 1.97; private only, OR: 1.48, 95% CI: 1.06-2.05) and not having a 
usual source of care was associated with a deceased likelihood of receiving guideline concordant treatment (OR: 
0.56, 95% CI: 0.43-0.72). Finally, need factors were associated with receipt of guideline concordant depression 
treatment: those with more health conditions and high service use were more likely to receive guideline 
concordant treatment, and those with excellent or very good health were less likely to receive guideline 
concordant treatment (OR: 1.08, 95% CI: 1.05-1.10; OR: 1.33, 95% CI: 1.21-1.58; OR: 0.82, 95% CI: 0.67- 0.99, 
respectively). 
 
 
 
 
 
